Background: Our purpose was to investigate the expression of FHIT (Fragile Histidine Triad) gene product in a series of 110 urinary bladder TCCs, and its eventual relationship with histological grade, clinical stage, recurrences and patients' survival.

Materials And Methods: We performed immunohistochemistry in archival material of formalin-fixed, paraffin-embedded tissues, using the anti-Fhit antibody and the Streptavidin-biotin peroxidase method.

Results: In 30 out of 110 cases (27.27%) Fhit protein was absent whereas in 32 cases (29.08%) it was abnormally expressed. In 48 cases (43.63%) Fhit protein was diffusely expressed in all tumor cells. A statistically highly significant correlation (p < 0.001) was noticed between Fhit protein absence or reduction and clinically advanced tumors. Conversely, abnormal Fhit protein expression was not associated with age, histological grade, tumor size, number of recurrences, and clinical outcome in terms of patients' survival.

Conclusions: These results confirm that FHIT gene inactivation is a late event in urinary bladder carcinogenesis. Fhit protein reduced expression or complete absence correlates with advanced clinical stage of the disease, and does not seem to correlate with tumor recurrences and patient survival.

Download full-text PDF

Source

Publication Analysis

Top Keywords

fhit protein
20
urinary bladder
12
fhit
8
fhit gene
8
histological grade
8
clinical stage
8
protein
5
expression
4
gene expression
4
expression human
4

Similar Publications

The tumor suppressor fragile histidine triad (FHIT) is frequently lost in non-small cell lung cancer (NSCLC). We previously showed that a down-regulation of FHIT causes an up-regulation of the activity of HER2 associated to an epithelial-mesenchymal transition (EMT) and that lung tumor cells harboring a FHIT/pHER2 phenotype are sensitive to anti-HER2 drugs. Here, we sought to decipher the FHIT-regulated HER2 signaling pathway in NSCLC.

View Article and Find Full Text PDF

Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.

BMC Cancer

December 2024

Department of Molecular Pathology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, No 127, Dongming Road, Zhengzhou, 450008, Henan, China.

Background: Esophageal cancer (ECa) is one of the most deadly cancers, with increasing incidence worldwide and poor prognosis. While endoscopy is recommended for the detection of ECa in high-risk individuals, it is not suitable for large-scale screening due to its invasiveness and inconvenience.

Methods: In this study, a novel gene methylation panel was developed for a blood-based test, and its diagnostic efficacy was evaluated using a cohort of 304 participants (203 cases, 101 controls).

View Article and Find Full Text PDF

Arabidopsis Fhit-like tumor suppressor resumes early terminated constitutive triple response1-10 mRNA translation.

Plant Physiol

June 2024

National Key Laboratory of Plant Molecular Genetics, CAS Center for Excellence in Molecular Plant Sciences, Institute of Plant Physiology and Ecology, Chinese Academy of Sciences, Shanghai 200032, China.

The Arabidopsis (Arabidopsis thaliana) constitutive triple response1-10 (ctr1-10) mutant produces a reduced level of CTR1 protein and exhibits a weak ctr1 mutant phenotype. Sequence analysis revealed highly active translation of the upstream open reading frame (uORF) at the extended 5'-UTR of the ctr1-10 mRNA, resulting from T-DNA insertion. Enhancer screening for ctr1-10 isolated the fragile histidine triad-1 (fhit-1) mutation.

View Article and Find Full Text PDF

Oral tongue squamous cell carcinoma (OTSCC) is the most common malignancy type among males across the world. However, analysis of molecular markers could be useful in detecting the early-stage OTSCC, which would allow optimal clinical treatments and prolong the survival rate of patients consequently. The study has the objective of detecting the role of salivary biomarkers based on gene promoter hypermethylation.

View Article and Find Full Text PDF

Long non-coding RNAs (lncRNAs) play a critical role in a variety of human diseases such as cancer. Here, to elucidate a novel function of a lncRNA called , we investigated its binding partner, target gene, and its regulatory mechanism in lung adenocarcinoma, including the A549 cell line and patients. In the A549 cell line, RNA immunoprecipitation (RIP) assays revealed that efficiently binds to SNAIL.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!